Royalty Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	26,657	16,509	11,334	12,497	17,432	17,116
Market Cap Growth	90.22%	45.66%	-9.30%	-28.31%	1.85%	-11.89%
Enterprise Value	34,989	27,726	21,332	21,132	27,333	26,687
Last Close Price	46.21	38.44	24.75	26.44	36.25	35.90
PE Ratio	25.94	21.41	13.20	11.01	407.00	27.62
Forward PE	9.13	7.70	6.10	7.47	10.32	13.00
PS Ratio	11.21	6.94	5.01	5.31	7.79	7.48
PB Ratio	3.06	1.70	1.10	1.24	1.83	1.67
P/TBV Ratio	4.80	2.97	1.63	1.92	3.11	2.97
P/OCF Ratio	10.71	6.63	4.09	4.18	8.13	8.48
PEG Ratio	0.73	0.79	2.14	2.65	0.94	1.12
EV/Sales Ratio	14.71	11.66	9.42	8.98	12.22	11.66
EV/EBITDA Ratio	22.38	17.74	-	14.11	29.44	18.36
EV/EBIT Ratio	22.44	17.78	16.51	14.16	29.62	18.65
Debt / Equity Ratio	0.92	0.92	0.74	0.61	0.75	0.69
Debt / EBITDA Ratio	5.74	5.74	-	4.10	7.66	4.88
Net Debt / Equity Ratio	0.86	0.86	0.64	0.56	0.56	0.48
Net Debt / EBITDA Ratio	5.33	5.33	-	3.77	5.79	3.38
Asset Turnover	0.13	0.13	0.13	0.14	0.13	0.14
Quick Ratio	2.39	2.39	1.43	7.78	2.11	16.77
Current Ratio	2.40	2.40	1.44	7.90	2.19	16.81
Return on Equity (ROE)	13.20%	13.20%	13.03%	17.34%	2.33%	12.32%
Return on Assets (ROA)	5.15%	5.15%	4.67%	5.62%	3.36%	5.33%
Return on Capital Employed (ROCE)	8.20%	8.20%	7.60%	9.20%	5.90%	8.20%
Earnings Yield	2.89%	4.67%	7.58%	9.08%	0.25%	3.62%
Dividend Yield	2.03%	2.29%	3.39%	3.03%	2.10%	1.89%
Payout Ratio	50.24%	49.06%	43.83%	31.57%	778.21%	46.02%
Buyback Yield / Dilution	4.99%	4.99%	1.46%	-37.66%	-5.59%	-10.48%
Total Shareholder Return	7.03%	7.28%	4.85%	-34.63%	-3.49%	-8.59%

Updated Feb 11, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q